We propose that on binding to actin at the start of the power stroke the myosin cross-bridge takes on the rigor configuration at the actin interface. Starting from the pre-power stroke state, this can be achieved by a small movement (16 rotation) of the lower 50K domain without twisting the central b-sheet or opening switch-1 or switch-2. The movement of the lower 50K domain puts a strain on the W-helix. This strain tries to twist the b-sheet, which could drive the power stroke. This would provide a coupling between actin binding and the execution of the power stroke. During the power stroke the b-sheet twists, moving the Ploop away from switch-2, which opens the nucleotide binding pocket and separates ADP from P i . The power stroke is different from the recovery stroke because the upper and lower 50K domains are tethered in the rigor configuration. (SRX) in which the myosin ATPase activity is strongly inhibited has been observed in a variety of muscle types. It has been proposed that myosin heads in this state are inhibited by binding to the core of the thick filament in a structure known as the "interacting-heads motif". The myosin inhibitor blebbistatin has been shown in structural studies to stabilize the interacting-heads motif. Here we have utilized measurements of single ATP turnovers to show that blebbistatin also stabilizes the SRX in both fast and slow skeletal muscle. We find that blebbistatin is more effective in stabilizing the SRX in slow skeletal fibers than in fast skeletal fibers. In the absence of blebbistatin, the SRX is destabilized if the myosin heads are not relaxed, e.g. rigor, rigor-ADP or activated. In the presence of blebbistatin the SRX is stable even in these conditions. A similar stability of the SRX is seen in tarantula fibers in the absence of blebbistatin. We show that spin-labeled nucleotides have an oriented spectrum in the SRX in slow skeletal muscle in the presence of blebbestatin that is similar to that observed in relaxed tarantula fibers in the absence of blebbistatin. This observation shows that the structure of the SRX is similar in different muscle types and in the presence and absence of blebbistatin. The conformation of the nucleotide site in the SRX is closed, with a conformation similar to that seen in other myosin nucleotide states as measured by the mobility of spin probes bound at the active site.
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Attached Molecular Motor in Trapped Single Molecule Assay as a Bi-Dimensional Brownian Multi-Stable System Lorenzo Marcucci, Toshio Yanagida. Osaka University, Suita (Osaka), Japan. To elucidate the physical properties of the force generation mechanism in molecular motors, we have obtained an analytical solution of the bi-dimensional Fokker-Plank equation which describes a common setup used in single molecule experiments. As a first application of this general result, we have shown that the size of the trapping system affects the dwell time of a multi-stable particle linearly. A quantitative application to skeletal actomyosin complex, using direct observation of force generation dynamics in the literature, shows that the size of the trapping system used was important for increasing the dwell time of the myosin head stable states to an observable time scale. Kinesiology, University of Massahcusetts, Amherst, MA, USA. Elevated levels of phosphate (P i ) reduce isometric force, providing support for the notion that the release of P i from myosin is closely associated with the generation of muscular force. P i is thought to rebind to actomyosin in an ADP-bound state and reverse the force-generating steps, including the rotation of the lever arm (i.e. the powerstroke). Despite extensive study this mechanism remains controversial in part because it fails to explain the effects of P i on isometric ATPase and unloaded shortening velocity. To gain new insight into this process, we determined the effect of P i on the force-generating capacity of a small ensemble of myosin (~12 myosin heads) using a three-bead laser trap assay. In the absence of P i , myosin pulled the actin filament an average distance of 54 5 4nm, translating into an average peak force of 1.2pN. By contrast in the presence of 30mM P i , myosin displaced the actin filament by only 13 5 1nm, generating just 0.2pN of force. The elevated P i also caused a >65% reduction in binding event lifetime, suggesting that P i induces premature detachment from a strongly-bound state. Definitive evidence of a P i -induced powerstroke reversal was not observed therefore we determined if a branched kinetic model in which P i induces detachment from a strongly-bound, post-powerstroke state could explain these observations. The model was not only able to accurately reproduce the present data but it was also able to reproduce the effect of P i on both isometric ATPase in muscle fibers and actin filament velocity in a motility assay. The ability of the model to capture the present as well as previous findings suggests that P i -induced inhibition of force may proceed along a different kinetic pathway from force-generation.
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Understanding the Effects of Cardiomyopathy Causing Mutations on Human Beta Cardiac Myosin Biomechanical Function Suman Nag, Ruth Sommese, Jongmin Sung, Elizabeth Choe, Masataka Kawana, Carol Cho, Rebecca Taylor, Chao Liu, Shirley Sutton, Kathleen Ruppel, James Spudich. Department of Biochemistry, Stanford University, Stanford, CA, USA. Cardiomyopathy is one of the leading causes of sudden cardiac death across the developed world. Over the last twenty years numerous single point mutations in the cardiac contractile apparatus have been implicated in hypertrophic and dilated cardiomyopathy (HCM or DCM), out of which nearly 40% of them are housed in the human b-cardiac myosin. Nonetheless, the underlying molecular effects of most of these mutations remain elusive. The cardiac muscle cyclically contracts under varying loads and it is likely that the mutations in the b-cardiac myosin affect the power output of the heart. We hypothesize that these mutations cause a fundamental mechanistic change in the power output of the cardiac myosin contractile system by either altering force or velocity of contraction, which ultimately compromises heart function and results in the clinical phenotypes. Using a combination of biochemistry and single molecule spectroscopy we show that two HCM-causing mutations (R403Q and R453C) in a truncated version of human b-cardiac myosin ending after the essential light chain (1-808) cause an increase in the power output by two different mechanisms. For R403Q we see a~20% increase in the maximum unloaded velocity, whereas for R453C the major change is a~50% increase in the intrinsic force generated by a single myosin head. On the other hand, with the DCM-causing S532P bcardiac myosin mutant both unloaded velocity and intrinsic force is decreased as compared to the wild type, predicting a lower power output. These results indicate that distinct molecular mechanisms for altering power output are operative for different cardiomyopathy-causing mutants. Work is currently being performed to understand these and other cardiomyopathy-causing mutations using an extended version of the human b-cardiac myosin molecule (1-843) with both human light chains. (b-MyHC) are the most frequent cause of Familial Hypertrophic Cardiomyopathy (FHC). For these mutations mutant and wildtype b-MyHC are co-incorporated in the contractile apparatus, and direct functional effects of such mutations presumably trigger development of the FHC-phenotype. In M. soleus biopsies of affected patients we previously found increased isometric force generation for the converter mutation R723G, most likely due to increased stiffness of the myosin head domain. Quantification of the increase in head stiffness from fiber studies, however, was complicated by filament compliance, as well as non-equal and variable co-expression of mutant and wildtype protein in the tissue samples.
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